SUNY Downstate Health Sciences University
School of Public Health
Past Featured Stories
Dr. Daniel Ehlke Receives the Office of Diversity Outreach and Research Excellence in Teaching Award
Dr. Marlene Camacho-Rivera Wins SUNY Prepare Innovation Seed Grant
Dr. Camacho-Rivera will be joined by co-investigators Aimee Afable, Ph.D., MPH, Associate Dean for Community Engagement and Associate Professor in the Department of Community Health Sciences; and Azure Thompson, DrPH, MPH, Community Health Sciences Assistant Professor; as well as SPH students Estela Cohetero and Yael Schechter, and College of Medicine student Colm Mulvaney as student researchers.
Dr. Paul Landsbergis and Graduate Student Researchers Contribute a Series of Healthy Work Strategies Case Studies about Efforts to Reduce COVID-19-Related Work Stressors
Dr. Marlene Camacho-Rivera Receives American Association for Cancer Research (AACR)-Minorities in Cancer Research Minority and Minority Serving Institution Faculty Award and Presents at AACR Virtual Symposium
Dr. Michael Szarek, Associate Dean for Research Administration and Executive Director
of the Center for Clinical and Outcomes Research, Published as Lead Author in European
DrPH Student, Eric Persaud, Publishes Article in the Association of Occupational Health Professionals in Healthcare (AOHP) Newsletter to Raise Awareness of Needlestick Injuries During Mass COVID-19 Vaccination Programs (Page 12-13)
Dean Dr. Kitaw Demissie Interviews with New York Amsterdams News on Coronavirus Variants and Vaccinations
Dr. Michael A. Joseph, Vice Dean for Academic and Student Affairs and Associate Professor of Epidemiology for the School of Public Health (SPH), Bids Downstate Adieu
Public Health Students from Dr. Lori Hoepner's Course Published in Leading Publications!
MPH Student, Jamila Taylor, Publishes Op-Ed in Queens Daily Eagle - 'Opinion: Older Adults Still Need Food and Support During the Pandemic. We Can Help'
Dr. Lori Hoepner Co-Authors a Chapter in New Textbook, "Disability Studies for Human Services: An Interdisciplinary and Intersectionality Approach"
Drs. Marlene Camacho-Rivera, Azure Thompson, and Aimee Afable Win SUNY Prepare Innovation Seed Grant to Conduct Research on Uptake of COVID-19 Vaccination Among High-Risk Groups
Dr. Kitaw Demissie Quoted in New York Amsterdam News - 'VAX PROS & CONS: Fears Linger Over Rushed Vaccine Rollout'
MPH Student, Rozanne Caesar, Publishes Op-Ed in Guyana Chronicle - 'The Plight of Elderly Caribbean Americans and COVID-19'
Dr. Lori Hoepner Shares Opinions with The Grist on Whether Hospitals Should Reprocess Medical Supplies
MPH Student, Camara Perkins, Publishes Op-Ed in New York Amsterdam News - 'Black Elders Deserve Free Therapy'
MPH Student, Sharon Billey, Publishes Op-Ed in New York Amsterdam News - 'Addressing Our Elderly—There’s a Hunger Epidemic Within the Pandemic'
SPH Faculty and Students' Research Successes Highlighted in SUNY Downstate's Inaugural Issue of Research Pulse Quarterly Newsletter
SUNY Downstate School of Public Health's DrPH and MPH Programs Ranked #11 by MPHonline.org!
Dr. Kitaw Demissie Interviews with NBC News - 'Inside the Massive COVID Testing Effort in the Beatles' Hometown'
Dr. Kitaw Demissie Quoted in New York Times - 'This Is How the Outbreak Is Resurgent Across New York City'
SUNY Downstate School of Public Health Becomes the Latest ASPPH Member Institution to Participate in SOPHAS
DrPH Student Judy Yan Publishes Dissertation Research on Association Between Triclocan Antimicrobal and White Blood Cell Counts
Dr. Michael Szarek Presents at American Heart Association Scientific Sessions 2020
Dr. Kitaw Demissie Discusses Second Wave of COVID-19 in the City, in New York Amsterdam News
SUNY Downstate Colleges and Schools Launches COVID-19 Surveillance Testing
School of Public Health Gets Ready for COVID-19 Surveillance Testing
Dr. Sergios Kolokotronis Publishes Long-Awaited International Genomic Investigation Into Coronavirus
Dr. Janet Rosenbaum Publishes a New Blog about her Recent Research on Contact Tracing for Syphilis and Gonorrhea, and How the COVID-19 Contact Tracking Apps Can Help
Dr. Daniel Ehlke Speaks at 2020 Translational Program of Health Disparities Research Training (TRANSPORT) Symposium
Dr. Kitaw Demissie Presents at NAACP New York State Conference 84th Annual Convention on COVID-19 Infections, Outcomes, and Racial Disparities
A Look at Dr. Marlene Camacho-Rivera's Incredible First Year
Double SPH Alumna and DrPH Student, Nihama Hoque, Selected as Public Health Officer in U.S. Air Force
Dr. Paul Landsbergis Presents at National Institute on Minority Health and Health Disparities (NIMHD) National Conference on Role of Work in Health Disparities
Past Research & Publications
Lipoprotein(a) Lowering by Alirocumab Reduces the Total Burden of Cardiovascular Events Independent of Low-Density Lipoprotein Cholesterol Lowering: ODYSSEY OUTCOMES Trial
Lipoprotein(a) concentration is associated with first cardiovascular events in clinical trials. It is unknown if this relationship holds for total (first and subsequent) events. In this study, Michael Szarek, PhD, MS, Executive Director of the Center for Clinical and Outcomes Research and Professor of Epidemiology and Biostatistics, and researchers concluded that baseline lipoprotein(a) predicted the risk of total cardiovascular events and risk reduction by alirocumab. Lipoprotein(a) lowering contributed independently to cardiovascular event reduction, supporting the concept of lipoprotein(a) as a treatment target after ACS.
Family History of Cancer Predicts Allergic Rhinitis and Asthma Development
Although past studies have evaluated the relationship between personal cancer diagnoses in individuals with asthma or allergy individuals, or by biomarkers such as immunoglobulin E, the heritability of such an effect, which may provide a survival benefit, has not been evaluated through family studies. In this research, Lori Hoepner, DrPH, MPH, Assistant Professor of the Department of Environmental and Occupational Health Sciences, and four researchers report three studies that extrapolate the allergy-cancer relationship to assess intergenerational risk.
Work Characteristics, Body Mass Index, and Risk of Obesity: The National Quality of Work Life Survey
DrPH alumna, Stephanie Myers, used multiple linear regression for BMI and multiple logistic regression for obesity to estimate associations with 19 work characteristics plus one set of occupational categories controlling for age, gender, race/ethnicity, education, marital status, job physical exertion, and television watching, and found that night shift schedule and blue-collar work were related to increased BMI and obesity risk in U.S. workers in 2014. Identifying risk factors in blue-collar work and redesigning jobs to reduce those risk factors, and reducing night shift work, could play a role in reducing the prevalence of obesity in the USA. Collaborators of this study included Drs. Usha Govindarajulu, Michael A Joseph, and Paul Landsbergis.
Excess Mortality in the United States During the First Three Months of the COVID-19 Pandemic
In this study, Janet Rosenbaum, PhD, Assistant Professor of the Department of Epidemiology and Biostatistics, estimates excess all-cause, pneumonia and influenza mortality during the coronavirus disease 2019 (COVID-19) pandemic using the 11 September 2020 release of weekly mortality data from the United States (U.S.) Mortality Surveillance System (MSS) from 27 September 2015 to 9 May 2020, using semiparametric and conventional time-series models in 13 states with high reported COVID-19 deaths and apparently complete mortality data: California, Colorado, Connecticut, Florida, Illinois, Indiana, Louisiana, Massachusetts, Michigan, New Jersey, New York, Pennsylvania and Washington.
Examining COVID-19 Preventive Behaviors among Cancer Survivors in the United States: An Analysis of the COVID-19 Impact Survey
The COVID-19 pandemic has impacted adults with chronic diseases, and their health care delivery. Patterns of COVID-19–related preventive behaviors practiced by cancer survivors are unknown, including practices related to canceling doctor's appointments. Marlene Camacho-Rivera, ScD, MS, MPH, Assistant Professor of the Department of Community Health Sciences, and two researchers evaluated nationally representative data of 10,760 U.S. adults from the COVID-19 Impact Survey and found that cancer survivors were more likely to practice preventive behaviors.
Gestational Diabetes Status and Dietary Intake Modify Maternal and Cord Blood Allostatic Load Markers
Allostatic load (AL) defines cardiometabolic, inflammatory, and neuroendocrine changes in the body in response to internal and external stressors. It is largely unknown whether gestational diabetes mellitus (GDM) alters maternal and fetal AL, which in turn affects GDM outcomes. Whether dietary intakes and quality can modify AL and thus influence GDM progression is also unknown. In this study, Lori Hoepner, DrPH, MPH, Assistant Professor of the Department of Environmental and Occupational Health Sciences, and researchers from the College of Medicine found that GDM status and dietary intakes modify AL in the sample population. AL may serve as an indicator of GDM control. Future research on dietary interventions that can improve maternal AL markers during GDM is warranted.
Barriers to Prostate Cancer Screening Among Indo Guyanese
Prostate cancer is one of the most common types of cancer in many industrialized countries and is among the leading causes of death. Our DrPH alumnus, Harrynauth (Harry) Persaud, DrPH, MSHS, PA-C, recently conducted a study for his dissertation work, attempting to explore the barriers to prostate cancer screening among Indo-Guyanese men. The study found four major themes to be the culprit associated with a decrease in prostate cancer screening in this population.
Denise Bruno, MD, MPH, and Aimee Afable, PhD, MPH, chaired and served on the dissertation committee, respectively.
Job Stress and Health of Elementary and Secondary School Educators in the United States
Elementary and secondary school educators face many work stressors, which appear to be increasing due to economic, political, and social trends. Therefore, Paul Landsbergis, PhD, MPH, EdD, Associate Professor for the Department of Environmental and Occupational Health Sciences, and MPH alumna, Elina Shtridler, along with other collaborators analyzed data from a 2017 national American Federation of Teachers survey of U.S. education staff, including data from two New York School districts that have adopted collaborative labor-management practices. Findings suggest the importance of reducing work stressors among U.S. educators.
Association between Urinary Triclosan and Serum Testosterone Levels in U.S. Adult Males from NHANES, 2011-2012
Triclosan was introduced into the market in the 1970s and has since been used as an antimicrobial agent in a diverse array of consumer and personal care products. Although it has been widely used over a number of years, there is growing concern and debate over its safety and efficacy and its potential as an endocrine disruptor. Using the National Health and Nutrition Examination Survey data (NHANES, 2011-2012), former DrPH student, Judy Yan, examined the association of urinary triclosan on testosterone levels in adult men 18-65 years of age.
Senior authors of this study included Michael Joseph, PhD, MPH (Vice Dean for Academic and Student Affairs, and Associate Professor of Epidemiology and Biostatistics), Simone Reynolds, PhD, MPH (Director of Online Learning and Instructional Innovation, and Assistant Professor of Epidemiology and Biostatistics), and Laura Geer, PhD, MHS (Chair and Associate Professor of Environmental and Occupational Health Sciences).
Effect of Alirocumab on Major Adverse Cardiovascular Events According to Renal Function in Patients with a Recent Acute Coronary Syndrome: Prespecified Analysis from the ODYSSEY OUTCOMES Randomized Clinical Trial
Statins reduce cardiovascular risk in patients with acute coronary syndrome (ACS) and normal-to-moderately impaired renal function. It is not known whether proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors provide similar benefit across a range of renal function. In this study, Michael Szarek, PhD, MS, Executive Director of the Center for Clinical and Outcomes Research and Professor of Epidemiology and Biostatistics, and researchers determined whether effects of the PCSK9 inhibitor alirocumab to reduce cardiovascular events and death after ACS are influenced by renal function.
Intensity of Statin Treatment After Acute Coronary Syndrome, Residual Risk, and Its Modification by Alirocumab: Insights from the ODYSSEY OUTCOMES Trial
Statins are pivotal to the secondary prevention of major adverse cardiovascular events, but some patients are statin-intolerant. In this study, Michael Szarek, PhD, MS, Executive Director of the Center for Clinical and Outcomes Research and Professor of Epidemiology and Biostatistics, and researchers examined the effects of the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor alirocumab on the risk of major adverse cardiovascular events according to the intensity of background statin treatment.
Evaluating Whether Young African-American Women Who Experience Reproductive Coercion or Birth Control Sabotage are More Likely to Become Pregnant
A recent systematic review estimated that 5–13% of young adult women attending family planning clinics have experienced reproductive coercion, with greater prevalence among non-Hispanic African-American women. Janet Rosenbaum, PhD, Assistant Professor of the Department of Epidemiology and Biostatistics, co-authored a study that estimates the 3-month and lifetime incidence of reproductive coercion and birth control sabotage using longitudinal data in a sample of African-American women at high risk of HIV and evaluates whether women’s experience of reproductive coercion predicts subsequent pregnancy.
Dr. Judith H. LaRosa Publishes 8th Edition of Women's Health Textbook
The 8th edition of New Dimensions in Women's Health has recently been published. In this new edition, Judith H. LaRosa, PhD, RN, Distinguished Service Professor for the Department of Health Policy and Managment, and the co-authors take great care to provide in-depth coverage of important aspects of women's health and to examine the contributing epidemiological, historical, psychosocial, cultural, ethical, legal, political, and economic influences. This textbook is written for undergraduate students within health education, nursing, and women's studies programs.
Sustained Low-Density Lipoprotein Cholesterol Lowering With Alirocumab in ODYSSEY OUTCOMES
In the ODYSSEY OUTCOMES (Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab) trial, alirocumab produced a marked reduction of low-density lipoprotein cholesterol (LDL-C) levels and significantly reduced the primary composite cardiovascular endpoint. In this study, Michael Szarek, PhD, MS, Executive Director of the Center for Clinical and Outcomes Research and Professor of Epidemiology and Biostatistics, and researchers addressed the question of whether rising LDL-C levels over time in alirocumab-assigned patients could also reflect time-dependent “attenuation” of the lipid-lowering efficacy of alirocumab.
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
Lipoprotein(a), a genetically determined low-density lipoprotein particle that contains apolipoprotein(a) and apolipoprotein B-100 moieties, is believed to possess pro-atherogenic, pro-thrombotic, pro-inflammatory, and pro-oxidative properties. In this study, Michael Szarek, PhD, MS, Executive Director of the Center for Clinical and Outcomes Research and Professor of Epidemiology and Biostatistics, and researchers found that baseline lipoprotein(a) and corrected LDL-C levels and their reductions by alirocumab predicted the risk of MACE after recent ACS. Lipoprotein(a) lowering by alirocumab is an independent contributor to MACE reduction, which suggests that lipoprotein(a) should be an independent treatment target after ACS.
Click here for news and articles published in the past editions of ASPPH Friday Letter.